经皮肝瘤内注入无水乙醇结合TACE治疗中晚期原发性肝癌的疗效观察  

Treatment of primary hepatic carcinoma with ultrasound guided percutaneous ethanol injection combined with transcatheter hepatic arterial chemoembolization

作　　者：徐永茂[1] 张南征[1] 张国龙[1] 徐卫东 史跃[3] 

机构地区：[1]解放军第九七医院消化肿瘤科,江苏徐州221004 [2]解放军第九七医院特诊科,江苏徐州221004 [3]解放军第九七医院放射科,江苏徐州221004

出　　处：《中国肿瘤临床与康复》2002年第4期78-80,共3页Chinese Journal of Clinical Oncology and Rehabilitation

摘　　要：目的　评估B超引导下经皮肝穿刺注射无水乙醇结合肝动脉化疗栓塞术治疗中晚期原发性肝癌的时机选择与疗效。方法　对 52例中晚期原发性肝癌采用B超引导下经皮肝穿刺瘤内注射无水乙醇 (PEI) +肝动脉插管化疗栓塞术 (TACE)治疗并与同期 58例单纯肝动脉化疗栓塞术 (对照组 )比较。结果　治疗组的肿瘤缩小率、AFP下降、Karnofsky评分、0 .5年、1年累计生存率明显优于对照组。Objective To estimate the curative effects on advanced primary hepatic carcinoma(PHC) treated by ultrasound guided percutaneous ethanol injection(PEI) combined with transcatheter hepatic arterial chemoembolization (TACE).Methods 52 patients with PHC treated by PEI and TACE(study group)were compared with 58 patients treated only by TACE (control group).Results The tumor shrinking rate,AFP decrease,survival rate of study group were significantly higher than those in control group.Conclusion The results indicate that PEI combined TACE is an effective method for patients with PHC.

关 键 词：经皮肝瘤内注入无水乙醇 TACE 治疗 中晚期 原发性肝癌 疗效观察 

分 类 号：R735.7[医药卫生—肿瘤]